Phase 4 Neuroendocrine Tumor Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms
Neuroendocrine TumorsNeuroendocrine Neoplasms
Shanghai Zhongshan Hospital350 enrolled4 locationsNCT07272512
Recruiting
Phase 4
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Metastatic Malignant Neoplasm in the LiverDigestive System Neuroendocrine Tumor G1Digestive System Neuroendocrine Tumor G2+3 more
Vanderbilt-Ingram Cancer Center6 enrolled1 locationNCT06016855
Recruiting
Phase 4
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
Pituitary AdenomaPituitary Neuroendocrine Tumor
Beijing Tiantan Hospital882 enrolled1 locationNCT06679816
Recruiting
Phase 4
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Gastroenteropancreatic Neuroendocrine Tumor
University Hospital, Antwerp270 enrolled19 locationsNCT05701241